Cutler Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,400
| Closed | -$1K | – | 858 |
|
|
2023
Q4 | $1K | Sell |
1,400
-111
| -7% | -$79 | ﹤0.01% | 1208 |
|
|
2023
Q3 | $1K | Hold |
1,511
| – | – | ﹤0.01% | 1284 |
|
|
2023
Q2 | $1K | Buy |
+1,511
| New | +$1K | ﹤0.01% | 1266 |
|
|
2022
Q3 | – | Sell |
-400
| Closed | – | – | 1873 |
|
|
2022
Q2 | $0 | Sell |
400
-100
| -20% | – | ﹤0.01% | 1852 |
|
|
2022
Q1 | $1K | Sell |
500
-8,000
| -94% | -$16K | ﹤0.01% | 1857 |
|
|
2021
Q4 | $31K | Buy |
8,500
+7,300
| +608% | +$26.6K | ﹤0.01% | 1340 |
|
|
2021
Q3 | $6K | Buy |
1,200
+700
| +140% | +$3.5K | ﹤0.01% | 1808 |
|
|
2021
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 1946 |
|
|
2021
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 1865 |
|
|
2020
Q4 | $2K | Sell |
500
-2,600
| -84% | -$10.4K | ﹤0.01% | 1637 |
|
|
2020
Q3 | $24K | Sell |
3,100
-3,800
| -55% | -$29.4K | ﹤0.01% | 1095 |
|
|
2020
Q2 | $69K | Buy |
+6,900
| New | +$69K | ﹤0.01% | 751 |
|
|
2020
Q1 | – | Sell |
-2,700
| Closed | -$3K | – | 1390 |
|
|
2019
Q4 | $3K | Hold |
2,700
| – | – | ﹤0.01% | 1355 |
|
|
2019
Q3 | $4K | Hold |
2,700
| – | – | ﹤0.01% | 1302 |
|
|
2019
Q2 | $10K | Sell |
2,700
-500
| -16% | -$1.85K | ﹤0.01% | 1273 |
|
|
2019
Q1 | $13K | Hold |
3,200
| – | – | ﹤0.01% | 1143 |
|
|
2018
Q4 | $18K | Sell |
3,200
-2,100
| -40% | -$11.8K | ﹤0.01% | 1119 |
|
|
2018
Q3 | $71K | Buy |
5,300
+700
| +15% | +$9.38K | ﹤0.01% | 838 |
|
|
2018
Q2 | $54K | Buy |
+4,600
| New | +$54K | ﹤0.01% | 881 |
|
|
2018
Q1 | – | Sell |
-300
| Closed | -$2K | – | 1749 |
|
|
2017
Q4 | $2K | Sell |
300
-100
| -25% | -$667 | ﹤0.01% | 1927 |
|
|
2017
Q3 | $3K | Buy |
+400
| New | +$3K | ﹤0.01% | 2206 |
|